Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally. Often diagnosed at advanced stages, the therapeutic ...
The TCR repertoire provides a novel platform for investigating the modulation of the TME post-TACE and the underlying mechanisms governing tumor development and recurrence. Clarifying the distinctive ...
T-cells that are part of our immune system are central in the protection against infections and cancer. With the help of TCRs, the cells recognize foreign invaders and tumor cells. “It was previously ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ BCR and the expansion of its ...
Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The ...
leads the IRS market through platforms such as NovaSeq X and AmpliSeq TCR kits, supported by its BaseSpace bioinformatics tools. The company's high-throughput solutions enable comprehensive TCR/BCR ...
Immune low-response states significantly impact the effectiveness of immunotherapy in cancer treatment. These states ...
Researchers have discovered that the genes encoding our T cell receptors vary greatly between persons and populations, which may explain why we respond differently to for example infections. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback